Insulin infusion increases levels of free IGF-I and IGFBP-3 proteolytic activity in patients after surgery

American Journal of Physiology - Endocrinology and Metabolism

Volumn 281, Issue 4 44-4, 2001, Pages

  Nygren, J ^a   Carlsson Skwirut, C ^b   Brismar, K ^b   Thorell, A ^a   Ljungqvist, O ^a   Bang, P ^b  

^a ERSTA HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Glucose clamp technique; Glucose homeostasis; Insulin resistance; Insulin like growth factor bioavailability

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTIVE SURGERY; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HUMAN; IMMUNORADIOMETRIC ASSAY; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; ULTRACENTRIFUGATION;

EID: 0034797472     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2001.281.4.e736     Document Type: Article

References (36)

1. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the ∼130- to 150-kDa ternary complex
2. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with non-insulin-dependent diabetes mellitus vs. healthy nonobese and obese subjects
3. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand
4. Postoperative induction of insulin-like growth factor binding protein-3 proteolytic activity: Relation to insulin and insulin sensitivity
5. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein- 3 results in increased availability of IGF to target cells
6. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes
7. The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery
8. The induction of a specific protease for insulin-like growth factor binding protein- 3 in the circulation during severe illness
9. IGF-I-stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM
10. Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline
11. Free insulin-like growth factors (IGF-I and IGF-II) in human serum
12. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: Effects of a pregnancy-associated serum protease activity
13. Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders
14. High ratios of free to total insulin-like growth factor-I in early infancy
15. Glucagon stimulates insulin-like growth factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency, and patients with insulin-dependent diabetes mellitus
16. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy
17. Use of glucose peroxidase and 0-dianisidin in determinations of blood and urinary glucose
18. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty
19. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans
20. A simple assay for proteolysis of IGFBP- 3
21. Regulation of IGF binding protein- 1 in Hep G2 cells by cytokines and reactive oxygen species
22. Role of the insulin-like growth factors in the endocrine control of glucose homeostasis
23. Overexpression of insulin-like growth factor binding protein- 1 in transgenic mice
24. Distributed anabolic hormonal patterns in burned patients: The relation to glucagon
25. Short-term hypocaloric nutrition but not bed rest decreases insulin sensitivity and IGF-I bioavailability in healthy subjects: The importance of glucagon
26. Site of insulin resistance after surgery: The contribution of hypocaloric nutrition and bed rest
27. Free insulin-like growth factor I (IGF-I) in healthy subjects: Relationship with IGF-binding proteins and insulin sensitivity
28. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid
29. Dose-response characteristics for effects of insulin on production and utilization of glucose in man
30. Levels of GH binding activity, IGFBP-1, insulin, blood glucose and cortisol in intensive care patients
31. Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: The possible role of insulin-like growth factor-binding protein- 3 proteolysis
32. Insulin-like growth factor-binding protein- 3 is functionally normal in pregnancy serum
33. Somatomedin-C/IGF-I measured by radioimmunoassay and somatomedin bioactivity in adolescents with insulin-dependent diabetes compared with puberty matched controls
34. Insulin resistance after abdominal surgery
35. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor-binding protein 3 protease
36. Modulation of insulin-like growth factor (IGF) and IGF binding protein biosynthesis by hypoxia in cultured vascular endothelial cells